News and Insights
The latest news and insights from Genoa Healthcare.
- Partner Highlights
- Pharmacy Openings
Announcing seven new pharmacy openings!
We’re excited to announce the opening of seven pharmacies last month. We welcome all new pharmacy staff to the team and are excited to partner with these organizations to serve...
- Sep 5th, 2023
- Behavioral Health
- Clinical Insights
- Treatment
September 2023 drug trend report
Genoa Healthcare’s latest drug trend report highlights information on new medication launches as well as noteworthy drug shortages currently in market. Brand name drug launches* Brixadi™ Zurzuvae™ (zuranolone) Generic drug...
- Sep 1st, 2023
- Genoa in the News
Genoa Healthcare featured in recent article about the important role of pharmacists
In a recent article featuring Genoa Healthcare, Chain Drug Review highlighted the important role pharmacy teams play in providing personalized, compassionate care to meet the needs of medically underserved communities....
- Aug 30th, 2023
- Behavioral Health
- Clinical Insights
Caring for those with treatment-resistant depression
Genoa Healthcare® can partner with you to improve outcomes for your patients living with TRD. Connect with us to get started today. One in three adults with major depressive disorder...
- Aug 9th, 2023
- Behavioral Health
- Clinical Insights
- Treatment
4 things to know about Spravato® (Intranasal esketamine)
Looking for information on Spravato®? Here are four things you should know. Spravato®: What, why and how? Spravato® is an FDA-approved nasal spray indicated for the treatment of treatment-resistant depression...
- Aug 9th, 2023
- Behavioral Health
- Clinical Insights
- Treatment
August 2023 drug trend report
Genoa Healthcare’s latest drug trend report highlights information on new medication launches as well as noteworthy drug shortages currently in market. Brand name drug launches* Uzedy Abilify Asimtuffii Brixadi Generic...
- Aug 2nd, 2023
- Behavioral Health
- Clinical Insights
- Treatment
Currently available and emerging therapy options for treatment-resistant depression
Studies show that 50% of people with major depressive disorder don’t respond adequately to initial antidepressant treatment.1 Additionally, an estimated 30% of people with major depressive disorder (MDD) experience treatment-resistant...
- Aug 2nd, 2023
- Consumer Stories
- Partnering with Genoa
Meeting needs and making days: How Genoa does pharmacy care differently
It’s not often you hear that someone looks forward to a pharmacy visit. But for one Genoa consumer, it’s a day-brightener every time she stops in. Dorothy has used the...
- Jul 12th, 2023
- Partner Highlights
- Pharmacy Openings
Announcing four new pharmacy openings!
We’re excited to announce the opening of four pharmacies last month. We welcome all new pharmacy staff to the team and are excited to partner with these organizations to serve...
- Jul 7th, 2023
- Partnering with Genoa
- People-first Pharmacy Care
Three ways to leverage a partnership with Genoa
Your team works hard to give the best care possible to the people you serve. Looking to lean on your pharmacy partner to support your staff and drive better outcomes...
- Jun 22nd, 2023